Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis, Relapse Free”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Study completedNCT00912860
What this trial is testing

Immunogenicity and Safety Study of Serum-Free Avonex

Who this might be right for
Multiple Sclerosis
Biogen 155
Not applicableStudy completedNCT02687919
What this trial is testing

Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
Amanda Irish 31
Large-scale testing (Phase 3)Study completedNCT01433497
What this trial is testing

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapse Free
AB Science 656
Early research (Phase 1)Study completedNCT02517788
What this trial is testing

Phase I BP Interferon (IFN) Beta-004

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Centre Hospitalier Universitaire Vaudois 24
Testing effectiveness (Phase 2)Study completedNCT01450488
What this trial is testing

Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AB Science 35